Delcath Systems to Participate at Upcoming Virtual Investor Conferences
08 mars 2021 09h00 HE
|
Delcath Systems, Inc.
NEW YORK, March 08, 2021 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of rare primary and metastatic cancers of the liver,...
Delcath Systems to Participate at Upcoming Virtual Investor Conferences
11 févr. 2021 09h00 HE
|
Delcath Systems, Inc.
NEW YORK, Feb. 11, 2021 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of rare primary and metastatic cancers of the liver,...
Delcath Systems to Present at the H.C. Wainwright Virtual BioConnect Conference
11 janv. 2021 10h56 HE
|
Delcath Systems, Inc.
NEW YORK, Jan. 11, 2021 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (Nasdaq: DCTH ), an interventional oncology company focused on the treatment of rare primary and metastatic cancers of the liver,...
Delcath Systems Announces Completion of Underwritten Public Offering
11 déc. 2020 10h31 HE
|
Delcath Systems, Inc.
NEW YORK, Dec. 11, 2020 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of rare primary and metastatic cancers of the liver,...
Delcath Systems Announces Pricing of Public Offering of Common Stock
09 déc. 2020 08h00 HE
|
Delcath Systems, Inc.
NEW YORK, Dec. 09, 2020 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of rare primary and metastatic cancers of the liver,...
Delcath Systems Announces Proposed Public Offering of Common Stock
08 déc. 2020 16h01 HE
|
Delcath Systems, Inc.
NEW YORK, Dec. 08, 2020 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of rare primary and metastatic cancers of the liver,...
Kevin Muir Joins Delcath Systems, Inc. as VP, Commercial Operations
07 déc. 2020 07h30 HE
|
Delcath Systems, Inc.
NEW YORK, Dec. 07, 2020 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (NASDAQ: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, today...
Delcath Systems, Inc. Announces Third Quarter 2020 Results
11 nov. 2020 08h00 HE
|
Delcath Systems, Inc.
NEW YORK, Nov. 11, 2020 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (NASDAQ: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, today...
Delcath Systems, Inc. to Participate in Oppenheimer Fall MedTech Summit on Thursday, November 12, 2020
02 nov. 2020 16h01 HE
|
Delcath Systems, Inc.
NEW YORK, Nov. 02, 2020 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (NASDAQ: DCTH), an interventional oncology company focused on liver-directed treatment of primary and metastatic cancers, today...
Delcath Schedules Conference Call to Report 2020 Third Quarter Financial Results
02 nov. 2020 09h00 HE
|
Delcath Systems, Inc.
NEW YORK, Nov. 02, 2020 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (NASDAQ: DCTH), an interventional oncology company focused on liver-directed treatment of primary and metastatic cancers, today...